Search Results - "Kalia, Y. N"

Refine Results
  1. 1

    Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins by Dubey, S., Kalia, Y.N.

    Published in Journal of controlled release (03-08-2010)
    “…The purpose of the study was to demonstrate the feasibility of using transdermal iontophoresis to deliver a functional protein, ribonuclease A (RNAse; 13.6…”
    Get full text
    Journal Article
  2. 2

    Skin penetration and distribution of polymeric nanoparticles by Alvarez-Román, R., Naik, A., Kalia, Y.N., Guy, R.H., Fessi, H.

    Published in Journal of controlled release (14-09-2004)
    “…Encapsulation using nanoparticulate systems is an increasingly implemented strategy in drug targeting and delivery. Such systems have also been proposed for…”
    Get full text
    Journal Article
  3. 3

    Novel micelle formulations to increase cutaneous bioavailability of azole antifungals by Bachhav, Y.G., Mondon, K., Kalia, Y.N., Gurny, R., Möller, M.

    Published in Journal of controlled release (30-07-2011)
    “…Efficient topical drug administration for the treatment of superficial fungal infections would deliver the therapeutic agent to the target compartment and…”
    Get full text
    Journal Article
  4. 4

    Effect of controlled laser microporation on drug transport kinetics into and across the skin by Bachhav, Y.G., Summer, S., Heinrich, A., Bragagna, T., Böhler, C., Kalia, Y.N.

    Published in Journal of controlled release (17-08-2010)
    “…The objectives of this study were to investigate a novel laser microporation technology ( P.L.E.A.S.E. Painless Laser Epidermal System) and to determine the…”
    Get full text
    Journal Article
  5. 5

    Understanding the poor iontophoretic transport of lysozyme across the skin: When high charge and high electrophoretic mobility are not enough by Dubey, S., Kalia, Y.N.

    Published in Journal of controlled release (10-06-2014)
    “…The original aim of the study was to investigate the transdermal iontophoretic delivery of lysozyme and to gain further insight into the factors controlling…”
    Get full text
    Journal Article
  6. 6

    Electrically-assisted delivery of an anionic protein across intact skin: Cathodal iontophoresis of biologically active ribonuclease T1 by Dubey, S., Kalia, Y.N.

    Published in Journal of controlled release (30-06-2011)
    “…Cathodal iontophoresis of anionic macromolecules has been considered a major challenge owing to (i) the presence of a negative charge on the skin under…”
    Get full text
    Journal Article
  7. 7

    Visualization of skin penetration using confocal laser scanning microscopy by Alvarez-Román, R, Naik, A, Kalia, Y.N, Fessi, H, Guy, R.H

    “…The use of skin as an alternative route for administering systemically active drugs has attracted considerable interest in recent years. However, the skin…”
    Get full text
    Book Review Journal Article
  8. 8

    Noninvasive Transdermal Iontophoretic Delivery of Biologically Active Human Basic Fibroblast Growth Factor by Dubey, S, Perozzo, R, Scapozza, L, Kalia, Y. N

    Published in Molecular pharmaceutics (01-08-2011)
    “…Human basic fibroblast growth factor (hbFGF; 17.4 kDa) has shown promise in the treatment of several dermatological conditions; symptomatic improvement was…”
    Get full text
    Journal Article
  9. 9

    Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo by Sekkat, N, Kalia, Y N, Guy, R H

    Published in Journal of pharmaceutical sciences (01-11-2002)
    “…The goal of this work was to establish, using biophysical characterization, that porcine ear skin in vitro is a valid model for its human counterpart…”
    Get more information
    Journal Article
  10. 10

    Factors and strategies for improving buccal absorption of peptides by Veuillez, F, Kalia, Y.N, Jacques, Y, Deshusses, J, Buri, P

    “…Peptides and polypeptides have important pharmacological properties but only a limited number (e.g. insulin, oxytocin, vasopressin) have been exploited as…”
    Get full text
    Book Review Journal Article
  11. 11

    Skin permeation enhancement by sucrose esters: A pH-dependent phenomenon by Cázares-Delgadillo, J., Naik, A., Kalia, Y.N., Quintanar-Guerrero, D., Ganem-Quintanar, A.

    Published in International journal of pharmaceutics (13-06-2005)
    “…The purpose of the present study was to evaluate the effect of sucrose esters (particularly, sucrose laureate and sucrose oleate in Transcutol ®) on the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Skin permeability enhancement by low frequency sonophoresis: lipid extraction and transport pathways by Alvarez-Román, R, Merino, G, Kalia, Y N, Naik, A, Guy, R H

    Published in Journal of pharmaceutical sciences (01-06-2003)
    “…The objective of this study was to shed light on the mechanism(s) by which low-frequency ultrasound (20 KHz) enhances the permeability of the skin. The…”
    Get more information
    Journal Article
  14. 14

    Iontophoresis: electrorepulsion and electroosmosis by Guy, Richard H., Kalia, Yogeshvar N., Delgado-Charro, M.Begoña, Merino, Virginia, López, Alicia, Marro, Diego

    Published in Journal of controlled release (14-02-2000)
    “…Over the last 10–15 years, the electrical enhancement of drug delivery across the skin has undergone intense investigation. During this period, considerable…”
    Get full text
    Journal Article Conference Proceeding
  15. 15

    Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue by Dubey, S, Perozzo, R, Scapozza, L, Kalia, Y N

    Published in International journal of pharmaceutics: X (01-12-2020)
    “…The first objective was to investigate the transdermal iontophoresis of interferon beta 1b (IFN); the second was to determine whether the addition of 10 Arg…”
    Get full text
    Journal Article
  16. 16

    Using protease inhibitors to improve protein stability in the presence of skin: A case study on the stability of insulin like growth factor 1 by Dubey, S., Perozzo, R., Scapozza, L., Kalia, Y.N.

    “…Insulin-like growth factor 1 (IGF-1) is indicated for growth failure in pediatric patients with primary IGF-1 deficiency and for patients with neutralizing…”
    Get full text
    Journal Article
  17. 17

    Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1b and a poly-Arg interferon beta-1b analogue by Dubey, S., Perozzo, R., Scapozza, L., Kalia, Y.N.

    Published in International journal of pharmaceutics (15-11-2020)
    “…[Display omitted] The first objective was to investigate the transdermal iontophoresis of interferon beta 1b (IFN); the second was to determine whether the…”
    Get full text
    Journal Article
  18. 18

    Development of an in vitro model for premature neonatal skin: biophysical characterization using transepidermal water loss by Sekkat, N, Kalia, Y N, Guy, R H

    Published in Journal of pharmaceutical sciences (01-12-2004)
    “…The objective was to develop an in vitro model for the developing skin of the premature neonate. Barriers of different levels of efficiency were produced by…”
    Get more information
    Journal Article
  19. 19

    Modeling transdermal drug release by Kalia, Yogeshvar N., Guy, Richard H.

    Published in Advanced drug delivery reviews (11-06-2001)
    “…The stratum corneum forms the outermost layer of the skin and is essentially a multilamellar lipid milieu punctuated by protein-filled corneocytes that augment…”
    Get full text
    Journal Article
  20. 20

    Contributions of electromigration and electroosmosis to iontophoretic drug delivery by MARRO, Diego, KALIA, Yogeshvar N, BEGONA DELGADO-CHARRO, M, GUY, Richard H

    Published in Pharmaceutical research (01-12-2001)
    “…To determine the electromigration and electroosmotic contributions to the iontophoretic delivery of lidocaine hydrochloride, in addition to the more-lipophilic…”
    Get full text
    Journal Article